Tüdőrák: vizsgálatok itt: Kína
1144 trials · From ClinicalTrials.gov, checked 2026. november 16.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleStudy on the Optimal Combination Pattern of the Combined Treatment of Radiotherapy and Immunotherapy for the Abscopal Effect in Non-Small Cell Lung Cancer (NSCLC) With Multiple Metastases
- Where
- Chongqing
- Életkor
- 18 év to 75 év
- People
- 366
- Run by
- Xinqiao Hospital of Chongqing
See details and how to joinNCT06953843 - No phaseTaking peoplePredicting Immunotherapy Response and Survival of Lung Cancer Patients Using Artificial Intelligence and Radiomics (Radiology-AI-Lung)
- Where
- Wuhan
- Életkor
- 18 év and over
- People
- 400
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07059923 - No phaseCsak meghívásosThe Effect of Semi-recumbent Position on Hypoxemia After Lung Segment/Lobe Surgery
- Where
- Shanghai
- Életkor
- 18 év to 85 év
- People
- 308
- Run by
- Shanghai Pulmonary Hospital, Shanghai, China
See details and how to joinNCT07060625 - 2. fázisTaking peopleRadiation Therapy Followed by Tislelizumab and Anlotinib Aeoadjuvant/Adjuvant Therapy for Stage II-IIIA NSCLC
- Where
- Hangzhou
- Életkor
- 18 év to 75 év
- People
- 20
- Run by
- Ji Yongling
See details and how to joinNCT06379087 - 1. fázisTaking peopleA Multi Tumor, Open Phase I Clinical Study on the Progression of First-line Anti-tumor Therapy Using Cardonizumab Combined With Pulsed Low-dose Rate External Irradiation (PLDR)
- Where
- Hefei
- Életkor
- 18 év to 75 év
- People
- 20
- Run by
- Anhui Provincial Hospital
See details and how to joinNCT06232083 - 1. fázisTaking peoplePhase I Study of BC008-1A Injection in Patients With Advanced Solid Tumors
- Where
- Tianjin
- Életkor
- 18 év and over
- People
- 80
- Run by
- Sichuan Luzhou Buchang Biopharmaceutical Co., Ltd.
See details and how to joinNCT06773507 - No phaseTaking peopleMultiple Omics Sequencing Technologies in Predicting the Efficacy and Monitoring the Recurrence of Non-Small Cell Lung Cancer
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 40
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07057102 - 1/2. fázisTaking peopleClinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor
- Where
- Shanghai
- Életkor
- 18 év to 70 év
- People
- 40
- Run by
- Shanghai Public Health Clinical Center
See details and how to joinNCT03093688 - No phaseTaking peopleMulti-omics Detection Techniques for Differentiating Benign and Malignant Pulmonary Nodules
- Where
- Suzhou
- People
- 150
- Run by
- Zhao Jun
See details and how to joinNCT07047573 - 1. fázisTaking peopleA Phase Ib Study of JMKX001899 in Combination With Other Therapies in Advanced NSCLC Harboring KRAS G12C Mutation
- Where
- Guangzhou
- Életkor
- 18 év to 75 év
- People
- 72
- Run by
- Jemincare
See details and how to joinNCT06946927 - 3. fázisTaking peopleA Confirmatory Clinical Study in NSCLC Patients With MET Exon 14 Mutation (KUNPENG-2)
- Where
- Guangzhou
- Életkor
- 18 év and over
- People
- 136
- Run by
- Beijing Pearl Biotechnology Limited Liability Company
See details and how to joinNCT05989542 - 2. fázisNot yet taking people in KínaA Prospective, Single-arm, Phase II Clinical Study of Tislelizumab Combined With Anlotinib and Platinum-based Doublet Perioperative Therapy for Resectable Stage II-IIIB Driver Gene-negative NSCLC
- Where
- Nanjing
- Életkor
- 18 év to 75 év
- People
- 40
- Run by
- The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT06977828 - No phaseTaking peopleOral Metronomic Vinorelbine and PD-1 Inhibitors in Elderly Non-small Cell Lung Cancer
- Where
- Hefei
- Életkor
- 65 év and over
- People
- 40
- Run by
- Anhui Chest Hospital
See details and how to joinNCT07041320 - No phaseTaking peopleRadiotherapy or Observation of Liver Metastases in Small Cell Lung Cancer
- Where
- Guiyang
- Életkor
- 18 év to 70 év
- People
- 66
- Run by
- Guizhou Medical University
See details and how to joinNCT05150145 - 2. fázisTaking peopleNeoadjuvant Sugemalimab + Chemotherapy Followed by Adjuvant Sugemalimab for Patients With Resectable Stage II-IIIA Non-small-cell Lung Cancer Patients
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 25
- Run by
- Shanghai Pulmonary Hospital, Shanghai, China
See details and how to joinNCT06987734 - No phaseTaking peopleThe Impact of AI Assistance on Radiologist Performance and Healthcare Costs in LDCT-Based Lung Cancer Screening
- Where
- Guangzhou
- Életkor
- 40 év to 74 év
- People
- 7294
- Run by
- The First Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT06988579 - 2. fázisNot yet taking people in KínaA Multicenter Phase II Randomized Trial of Limertinib Followed by Sintilimab and Chemotherapy vs. Limertinib Followed by Limertinib and Chemotherapy as Neoadjuvant Therapy in Resectable Stage II-IIIB EGFR-Mutant NSCLC
- Where
- Changsha, Guangzhou, Hangzhou
- Életkor
- 18 év to 75 év
- People
- 134
- Run by
- Wen-zhao ZHONG
See details and how to joinNCT07038460 - No phaseNot yet taking people in KínaEnteral Nutrition With L-Carnitine for Cachexia in Non-Small Cell Lung Cancer
- Where
- Chongqing
- Életkor
- 18 év and over
- People
- 126
- Run by
- Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
See details and how to joinNCT07035444 - No phaseNot yet taking people in KínaEfficacy and Safety of Chemoimmunotherapy and Carbon Ion Radiotherapy in Unresectable Locally Advanced Non-small Cell Lung Cancer
- Where
- Hangzhou
- Életkor
- 18 év to 75 év
- People
- 34
- Run by
- Ji Yongling
See details and how to joinNCT07035860 - 1. fázisNot yet taking people in KínaA Clinical Trail of KJ015 in Patients With HER2-Expressing Solid Tumors
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 66
- Run by
- Shanghai Bao Pharmaceuticals Co., Ltd.
See details and how to joinNCT07036185 - 3. fázisTaking peopleSSGJ-707 in Advanced Non-Small Cell Lung Cancer
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 420
- Run by
- Shenyang Sunshine Pharmaceutical Co., LTD.
See details and how to joinNCT06980272 - 2/3. fázisTaking peopleElectroacupuncture Combined With Immune Checkpoint Inhibitors as Adjuvant Therapy After Surgery for Early-stage Non-small Cell Lung Cancer
- Where
- Tianjin
- Életkor
- 18 év to 80 év
- People
- 405
- Run by
- Kong Fanming
See details and how to joinNCT07034326 - 2. fázisTaking peopleA Study Evaluating the Efficacy of PD-1 Inhibitor Combined With Denosumab and Chemotherapy in Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer Patients With Driver Gene-Negative Status
- Where
- Shenyang
- Életkor
- 18 év to 75 év
- People
- 40
- Run by
- China Medical University, China
See details and how to joinNCT07034391 - 2. fázisNot yet taking people in KínaA Single-arm, Multicenter, Prospective Clinical Study of Adebrelimab Combined With Apatinib Neoadjuvant Therapy for Resectable Non-small Cell Lung Cancer
- Where
- Xiamen
- Életkor
- 18 év to 70 év
- People
- 43
- Run by
- The First Affiliated Hospital of Xiamen University
See details and how to joinNCT07031154 - 2. fázisTaking peopleDZD9008 In Combination With Bevacizumab in Locally Advanced or Metastatic NSCLC Patients With EGFR Mutation (WU-KONG29)
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 60
- Run by
- Dizal Pharmaceuticals
See details and how to joinNCT06276283